You searched for "true transparency". Here are the results:
Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, House Bill 1260, Prescription Drug Price Transparency. We need your help to contact your legislator UR... Read More
As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs selected earlier this month, it is reaching out to stakeholders to request their engagement in the affordability review process via their Stakeholder Engagement Guide. Speci... Read More
Get weekly updates from Colorado’s leading source for life sciences news and information. Read More
2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Governor. This was a crowded race with the Democratic party candidate Jared Polis and the Republican Party... Read More
This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summarized President Trump’s blue print. For more information on the blueprint click here and to view the... Read More
This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to meet with CBSA member companies, industry partners, and other bioscience supporters. The convention... Read More
Collaborating on True Transparency to Benefit Patients Our state’s bioscience innovators work to create wearable devices to help make us healthier, develop drugs that could save a loved one from cancer, and identify disease-causing viruses and bacteria in food and water before they can make people s... Read More
As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription drugmakers are a familiar target for those looking to place blame on rising out-of-pocket costs to p... Read More
UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the advanced industries export acceleration program to businesses looking to expand and grow their busin... Read More
Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering our complex health care system as a whole to make positive changes for patients and their families.... Read More
Networking +
Policy +
Member
Career
Choose